Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NVAX save search
U.S. CDC Advisory Committee Unanimously Recommends Novavax COVID-19 Vaccine, Adjuvanted as a Primary Series for Individuals Aged 18 and Older
Published: 2022-07-19 (Crawled : 21:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -0.16%
H: 11.38%
C: 2.87%
covid-19
Novavax Announces Expanded Agreement with SK bioscience to Manufacture COVID-19 Vaccine Containing Omicron Variant and Manufacture the Novavax COVID-19 Vaccine in Prefilled Syringes
Published: 2022-07-19 (Crawled : 13:00) - biospace.com/
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 1.44%
H: 13.25%
C: 10.02%
covid-19 vaccine agreement bioscience
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Individuals Aged 18 and Over
Published: 2022-07-13 (Crawled : 22:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -4.42%
H: 2.36%
C: -22.79%
covid-19 fda grants authorization emergency use authorization
U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 Vaccine
Published: 2022-07-11 (Crawled : 12:20) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -2.67%
H: 1.68%
C: -9.36%
covid-19 vaccine
Novavax Nuvaxovid™ COVID-19 Vaccine Conditionally Authorized in the European Union for Adolescents Aged 12 Through 17
Published: 2022-07-05 (Crawled : 14:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -0.68%
H: 13.79%
C: 13.27%
covid-19 authorized vaccine
NOVAVAX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Novavax, Inc. - NVAX
Published: 2022-07-02 (Crawled : 04:20) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
| Email alert
Add to watchlist
initiated
Novavax COVID-19 Data Presented at FDA VRBPAC Meeting Demonstrates Broad Antibody Responses to Both Prototype and Omicron-Specific Variants
Published: 2022-06-28 (Crawled : 23:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -2.27%
H: 6.45%
C: 3.91%
covid-19 fda antibody meeting prototype
Novavax COVID-19 Vaccine Nuvaxovid™ Recommended for Expanded Conditional Marketing Authorization in the European Union by CHMP for Adolescents Aged 12 Through 17
Published: 2022-06-23 (Crawled : 19:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -0.06%
H: 0.5%
C: -0.21%
covid-19 chmp vaccine authorization
Novavax COVID-19 Vaccine Nuvaxovid™ Provisionally Registered in Australia as a Booster in Individuals Aged 18 and Over
Published: 2022-06-13 (Crawled : 12:00) - biospace.com/
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -4.23%
H: 3.34%
C: -6.74%
covid-19 australia vaccine
FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and Older
Published: 2022-06-07 (Crawled : 22:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 10.03%
H: 1.22%
C: -4.21%
covid-19 fda vaccine authorization order emergency use authorization
Novavax Reports First Quarter 2022 Financial Results and Operational Highlights
Published: 2022-05-09 (Crawled : 22:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.69%
H: 0.28%
C: -1.1%
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 0.09%
H: 5.27%
C: -7.13%
results
Novavax to Host Conference Call to Discuss First Quarter 2022 Financial Results and Operational Highlights on May 9, 2022
Published: 2022-05-02 (Crawled : 21:00) - biospace.com/
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -0.38%
H: 19.8%
C: 19.71%
conference results
FDA Announces Vaccines and Related Biological Products Advisory Committee Review of Novavax' COVID-19 Vaccine
Published: 2022-04-29 (Crawled : 19:00) - biospace.com/
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 3.79%
H: 14.21%
C: -1.92%
covid-19 fda vaccine review
Novavax Announces Initiation of COVID-19 Vaccine Booster Study in Adolescents in Phase 3 PREVENT-19 Trial
Published: 2022-04-22 (Crawled : 12:00) - biospace.com/
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -12.19%
H: 4.08%
C: -1.27%
covid-19 vaccine trial phase 3
Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine
Published: 2022-04-20 (Crawled : 17:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -1.1%
H: 5.48%
C: -0.56%
covid-19 vaccine trial results
Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster Immunization in Japan
Published: 2022-04-19 (Crawled : 12:00) - biospace.com/
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -9.57%
H: 4.12%
C: 2.61%
covid-19 japan vaccine approval
Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious Diseases
Published: 2022-04-18 (Crawled : 19:00) - biospace.com/
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 0.48%
H: 0.0%
C: 0.0%
vaccine disease
Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious Diseases
Published: 2022-04-18 (Crawled : 14:00) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 0.48%
H: 0.0%
C: 0.0%
vaccine disease
Swissmedic Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine
Published: 2022-04-13 (Crawled : 11:00) - biospace.com/
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 0.38%
H: 7.96%
C: 6.6%
covid-19 vaccine authorization covid grant
Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand
Published: 2022-04-08 (Crawled : 13:20) - prnewswire.com
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: 0.27%
H: 6.52%
C: 1.63%
covid-19 vaccine authorization india emergency use authorization
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.